Unassociated Document
UNITED
STATES
SECURITIES
AND
EXCHANGE COMMISSION
Washington,
D.C.
20549
FORM
25
NOTIFICATION
OF REMOVAL FROM LISTING AND/OR
REGISTRATION
UNDER SECTION 12(b) OF THE
SECURITIES
EXCHANGE ACT OF 1934.
Commission
File
Number 1-15096
Merck
Serono S.A., The
New
York Stock Exchange
_____________________________________________________________________________________________________________
(Exact
name of
Issuer as specified in its charter, and name of Exchange where security is
listed and/or registered)
9,
Chemin
des Mines, Case Postal 54, CH-1202 Geneva, Switzerland Telephone
+41-22-414-3000
_____________________________________________________________________________________________________________
(Address,
including
zip code, and telephone number, including area code, of Issuer’s principal
executive offices)
Bearer
Shares, nominal value CHF 25 per share
American
Depositary Shares (as evidenced by American Depositary Receipts), each
representing one fortieth of a Bearer Share
_____________________________________________________________________________________________________________
(Description
of
class of securities)
Please
place an X
in the box to designate the rule provision relied upon to strike the class
of
securities from listing and registration:
o 17
CFR
240.12d2-2(a)(1)
o 17
CFR
240.12d2-2(a)(2)
o 17
CFR
240.12d2-2(a)(3)
o 17
CFR
240.12d2-2(a)(4)
o Pursuant
to 17 CFR
240.12d2-2(b), the Exchange has complied with its rules to strike the class
of
securities from listing and/or withdraw registration on the
Exchange.
x Pursuant
to 17 CFR
240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the
requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of
the
class of securities from listing and registration on the Exchange.
Pursuant
to the
requirements of the Securities Exchange Act of 1934, Merck Serono S.A. certifies
that it has reasonable grounds to believe that it meets all of the requirements
for filing the Form 25 and has caused this notification to be signed on its
behalf by the undersigned duly authorized person.
April
16,
2007 By
/s/ Francois
Naef
Chief Administrative Officer
Date Name
Title